Mumps is a highly contagious viral infection with an incubation period of 14-18 days from exposure to onset of symptoms. The duration of the disease is approximately 10 days. The initial symptoms of mumps infection are nonspecific (low-grade fever, malaise, headache, muscle aches, and loss of appetite). The classic finding of parotid gland tenderness and swelling generally develops the third day of illness. The diagnosis is generally made without the need for laboratory tests. Serious complications of mumps include meningitis, encephalitis, deafness, and orchitis. The MMR vaccine provides 80% effective immunity against mumps following a twodosage schedule (12-15 months with booster at 4-6 years of age). No specific therapy exists for mumps. Warm or cold packs for the parotid gland tenderness and swelling is helpful. Pain relievers (acetaminophen [Tylenol] and ibuprofen [Advil]) are also helpful.
What is mumps?
Mumps is a viral infection transmitted by and affecting only humans. While the salivary glands (especially the parotid gland) are well known to be involved during a mumps infection, many other organ systems may also experience viral effects. There is no cure for mumps, but the illness is of short duration (seven to 10 days) and resolves spontaneously. Prior to the introduction of mumps vaccination, the highest rate of new cases of mumps was reported in the late winter to early spring.
What are the signs and symptoms of mumps in children and adults?
Nonspecific symptoms of low-grade fever, headache, muscle aches (myalgia), reduced appetite, and malaise occur during the first 48 hours of mumps infection. Parotid gland swelling characteristically is present on day three of illness. (The parotid gland is a salivary gland located anterior to the ear and above the angle of the jaw -- imagine a large set of sideburns.) The parotid gland is swollen and tender to touch, and referred pain to the ear may also occur. Parotid gland swelling may last up to 10 days, and adults generally experience worse symptoms than children.
Approximately 95% of individuals who develop symptoms of mumps will experience tender inflammation of their parotid glands. Interestingly about 15%-20% of mumps cases have no clinical evidence of infection, and 50% of patients will have only nonspecific respiratory symptoms and not the characteristic description above. Adults are more likely to experience such a subclinical or respiratory-only constellation of symptoms while children between 2-9 years of age are more likely to experience the classic presentation of mumps with parotid gland swelling.
2. Encephalitis: Until the 1960s mumps was the primary cause of confirmed viral encephalitis in the United States. Since the successful introduction of a vaccination program, the incidence of mumps encephalitis has fallen to 0.5%. Fortunately, most patients recover completely without permanent side effects.
3. Deafness: Preceding the mumps vaccination program, permanent nerve damage resulting in deafness was not unusual. While occasionally bilateral, more commonly only one ear was affected.
4. Orchitis: This complication was the most common side effect (40%) to postpubertal males who contracted mumps. Severe pain (often requiring hospitalization for pain management) was one-sided in 90% of cases. Between 30%-50% of affected testes atrophied (decreased in size), and 13% demonstrated impaired fertility. The "common knowledge" of sterility was actually rare. Previous concerns regarding mumps orchitis and later testicular cancer have not been proven. (Ovarian involvement occurred in approximately 7% of postpubertal girls.) Less frequent complications of mumps infection include arthritis, infection of the pancreas, infection of the myocardium (heart muscle), and neurological conditions (for example, facial palsy, Guillain-Barr syndrome, etc.).
Multiple international studies have not demonstrated any causative relationship between administration of the MMR vaccine and the development of autism.